biophamaceutical research

• 

  GB Sciences Files Patent Application for Chronic Pain and Heart Therapies

  3:17 PM | May 23, 2017

  LAS VEGAS, May 23, 2017, GBLX, /PRNewswire/ — GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the filing of its latest patent application by its wholly-owned subsidiary, Growblox Life Sciences, LLC for the treatment of chronic pain and heart therapies based on myrcene-containing complex mixtures (“MCCM”). The current US opioid epidemic, along with growing public and government concern regarding opioid abuse, makes new pain treatments a promising field of research and development. Our novel pain formulations are also substantially free of

  Read more

• Medient Studios to Present at the Growth Capital Expo at Caesar’s Palace, Las Vegas, Nevada

  1:55 PM | April 22, 2014

  EFFINGHAM COUNTY, GA, Apr 22, 2014 (Marketwired via COMTEX) — Medient Studios, Inc. (OTCQB: MDNT) (‘Medient’) announced today that it will present to various investment banks, fund managers, institutional and high net worth investors at the Growth Capital Expo (‘GCE’) in Las Vegas, Nevada on April 29th-May 1, 2014. Manu Kumaran, Chairman of the Board of Medient, stated, “We made a promise to our shareholders to become more aggressive in educating Wall Street about Medient and the Studioplex. Through similar

  Read more